产品型号:磷酸化核糖体S6蛋白激酶β2抗体 产品厂商:KALANG 产品文档: 简单介绍: Anti-Phospho-p70 S6 Kinase Beta (Thr444 + Ser447)抗体产品质量稳定,实验效果明显,货期快,价格优惠,欢迎垂询订购!我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆...
S6 kinase, whereas both modifications together produce 20–30-fold more activity than either alone. We employed phospho-specific anti-peptide antibodies to examine the relative phosphorylation at several of these sites in wild type and various p70 mutants, in serum-deprived cells, and in response ...
Description:Rabbit polyclonal antibody to p70 S6K (phospho-S424) Specificity:p-p70 S6K (S424) pAb detects endogenous levels of p70 S6 kinase only when phosphorylated at Ser424. This antibody also detects p85 S6 kinase when phosphorylated at Ser447. ...
Galbaugh, et al., “EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation” BMC Cell Biol., 2006, pp. 34, vol. 7. Garcia, et al., “Constitutive activation of Stat3 by the Src and JAK tyrosine kinases...
millipore MABS82 Consumables Anti-phospho-p70 S6 Kinase (Thr389). EA 3,850.00 millipore MABS826 Consumables Anti-Rsk1, clone 3G5.1 EA 4,060.00 millipore MABS87 Consumables Anti-GPR177, clone YJ5 EA 3,190.00 millipore MABS89 Consumables Anti-GRB-2, clone 7G10.1 EA 3,850.00 millipore ...
Immunoway YP0213 Phospho-p70 S6 kinase α (S434) Polyclonal Antibody Human,Mouse,Rat,Monkey WB,IHC,ELISA 20ug/700, 50ug/1500, 100ug/2800 Immunoway YP0214 Phospho-p70 S6 kinase α (S447) Polyclonal Antibody Human,Mouse,Rat WB,IHC,ELISA 20ug/700, 50ug/1500, 100ug/2800 Immunoway YP0215...
We observed an increase in the phosphorylation of mitogen- and stress-activated kinase 2 (MSK2), p38α MAPK, 90-kD ribosomal protein kinase 1 (RSK1), Akt1, and p70S6 kinase (p70S6K). Antibody 4B9 effectively blocked the phosphorylation of all the downstream signaling proteins activated by ...
Antibodies to phospho-mTOR Ser-2448 (D9C2, #5536), phospho-p70S6K Thr-389 (108D2, #9234), phospho-AKT Ser-473 (D9E, #4060), phosphor-GSK-3β Ser-9 (D85E12, #5558), phosho-ERK1/2 Thr-202/Tyr-204 (D13.14.4E, #4370), phosho-S6 ribosomal protein Ser-235/236 (91B2, ...
In preclinical studies, YIV-906 was shown to enhance the anti-tumor activity of different classes of anti-cancer agents, including immune checkpoint inhibitors, tyrosine kinase inhibitors, topoisomerase inhibitors, anti-microtubule agents, alkylating agents, antimetabolites, and radiation in vivo12. YIV...